HomeComparePAVMZ vs KMB

PAVMZ vs KMB: Dividend Comparison 2026

PAVMZ yields 222222.22% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PAVMZ wins by $1.4076447531278624e+30M in total portfolio value
10 years
PAVMZ
PAVMZ
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076447531278624e+30M
Annual income
$1,406,399,782,569,334,400,000,000,000,000,000,000.00
Full PAVMZ calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — PAVMZ vs KMB

📍 PAVMZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPAVMZKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PAVMZ + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PAVMZ pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PAVMZ
Annual income on $10K today (after 15% tax)
$18,888,888.89/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,815,183,934,200,000,000,000,000,000,000.00/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, PAVMZ beats the other by $1,195,439,815,183,934,200,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PAVMZ + KMB for your $10,000?

PAVMZ: 50%KMB: 50%
100% KMB50/50100% PAVMZ
Portfolio after 10yr
$7.038223765639312e+29M
Annual income
$703,199,891,284,667,200,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

PAVMZ
No analyst data
Altman Z
-10.4
Piotroski
4/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PAVMZ buys
0
KMB buys
0
No recent congressional trades found for PAVMZ or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPAVMZKMB
Forward yield222222.22%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$1.4076447531278624e+30M$45.9K
Annual income after 10y$1,406,399,782,569,334,400,000,000,000,000,000,000.00$5,211.33
Total dividends collected$1.4075632434891558e+30M$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PAVMZ vs KMB ($10,000, DRIP)

YearPAVMZ PortfolioPAVMZ Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$22,232,922$22,222,222.22$11,314$613.68+$22.22MPAVMZ
2$46,198,082,523$46,174,293,296.41$12,865$759.19+$46198.07MPAVMZ
3$89,718,752,943,223$89,669,320,994,923.30$14,709$943.96+$89718752.93MPAVMZ
4$162,845,393,609,755,680$162,749,394,544,106,430.00$16,919$1,180.17+$162845393609.74MPAVMZ
5$276,249,735,879,778,500,000$276,075,491,308,616,120,000.00$19,588$1,484.33+$276249735879778.47MPAVMZ
6$437,989,462,258,048,500,000,000$437,693,875,040,657,100,000,000.00$22,838$1,879.06+$437989462258048512.00MPAVMZ
7$649,026,142,700,674,900,000,000,000$648,557,493,976,058,700,000,000,000.00$26,832$2,395.60+$649026142700674875392.00MPAVMZ
8$898,874,153,179,794,200,000,000,000,000$898,179,695,207,104,400,000,000,000,000.00$31,788$3,077.63+$8.988741531797941e+23MPAVMZ
9$1,163,523,886,474,633,300,000,000,000,000,000$1,162,562,091,130,731,000,000,000,000,000,000.00$38,000$3,986.82+$1.1635238864746333e+27MPAVMZ
10$1,407,644,753,127,862,300,000,000,000,000,000,000$1,406,399,782,569,334,400,000,000,000,000,000,000.00$45,872$5,211.33+$1.4076447531278624e+30MPAVMZ

PAVMZ vs KMB: Complete Analysis 2026

PAVMZStock

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Full PAVMZ Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this PAVMZ vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PAVMZ vs SCHDPAVMZ vs JEPIPAVMZ vs OPAVMZ vs KOPAVMZ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.